$WST · WEST PHARMACEUTICAL SERVICES INC SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for WEST PHARMACEUTICAL SERVICES INC ($WST) from October 29, 2026 through October 29, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$WST 10-Q — WEST PHARMACEUTICAL SERVICES INC
West's 53% net income jump and aggressive $685.3M buyback signal management confidence, but the SmartDose divestiture and West Vantage decline raise questions about non-Propriet…
$WST 8-K — WEST PHARMACEUTICAL SERVICES INC
Beat-and-raise quarter with 57% EPS growth, aggressive $685M YTD buyback, and HVP Components now majority of sales — a structural margin story accelerating.